Skip to content

Impacts of Lentils on Metabolism and Inflammation

Gut Microbiota Dependent and Independent Impacts of Dietary Pulses on Pre- and Postprandial Metabolism and Inflammation in Overweight/Obese Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04283448
Enrollment
38
Registered
2020-02-25
Start date
2020-05-22
Completion date
2023-11-19
Last updated
2024-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemia, Inflammation, Waist, Hypertriglyceridemic

Brief summary

The overall goal of this investigation is to determine gut microbiome dependent and independent impacts of pulse consumption on metabolic resilience and metabolic risk profiles for type 2 diabetes (T2D) and cardiovascular disease (CVD) risk. Specifically, pulse crop consumption has unrealized potential to fundamentally alter how the body responds to disease promoting metabolic stresses of postprandial triglyceride and inflammation responses. The specific objectives are to (1) Determine the impact of green lentil consumption on postprandial triglyceride (TG) and inflammation responses to a high-fat meal challenge. (2) Determine the extent to which the gut microbiome and changes in the gut microbiome induced by pulse consumption influence health impacts (3) Measure metabolomic profiles to elucidate underlying mechanisms linking pulse consumption to improved health. To achieve these objectives investigators will determine the effects of green lentil on high impact risk factors of large postprandial triglyceride excursions and inflammation, composition of and changes in the gut microbiomes, and both gut and serum metabolomes in overweight/obese (OW/OB) individuals with elevated risk. The 12-week intervention will consist of consumption of 4.6 or 0 cups of pulses per week across 7 pre-made meals (matched for macronutrient content (except fiber) provided to experimental and control groups. The following hypotheses will be tested in the proposed investigation: H1: Lentil consumption lower postprandial TG and inflammation responses and improve overall metabolic health. H2: Characteristics of the gut microbiome and changes in the gut microbiome induced by lentil consumption substantially influence health impacts of pulse consumption. H3: Features of the fecal and serum metabolomes distinguishing lentil and control treatments correspond to metabolic pathways elucidating potential gut microbiome dependent and independent mechanisms linking pulse consumption to improved health.

Detailed description

Investigators will utilize a parallel intervention of lentil versus macronutrient-matched (not including fiber) control treatment for 12 weeks in OW/OB adults with demonstrated risk for T2D and CVD. Experimental diets will be provided to participants in the form of pre-made midday meals to exploit the second meal effect and lower caloric intake at the evening meal. Pre- and post-intervention assessments will be made for the following variables: makeup of the gut microbiome (microbial species and relative abundance), gut metabolome, postprandial response of TG, inflammatory cytokines, and serum metabolome to a high-fat meal challenge (established inflammation stimulus), fasting serum glucose, lipid, insulin, inflammation markers and metabolome, blood pressure, and anthropometric measures including weight, body composition, waist circumference, and quantity of visceral adipose tissue. Habitual diet will be measured so that these variables can be used to aid in our characterization of participants and aid in analysis and interpretation of data. Procedures: Postprandial lipidemic and inflammation responses: High-fat meal challenges with 40 to 100 g of dietary fat are an established laboratory test to measure both postprandial triglyceridemic and inflammation responses. Investigators have used a 50 g dose of fat delivered in the form of butter on toast on \> 50 individuals because this particular dose is effective at discriminating between low versus high TG and inflammation responders. In brief, participants will report to the laboratory after an overnight fast, an indwelling venous catheter will be placed in an antecubital vein, and blood samples will be collected before, and 1, 2, 3, 4, and 5 hours following ingestion of the high-fat meal. Samples will be analyzed in real time for TG (and full lipid panel plus glucose) using a clinical chemistry analyzer (Piccolo xpress), while serum samples will be aliquoted and stored at -80 C until analysis for inflammatory cytokines, metabolomics, and insulin. Investigators will measure inflammatory cytokines (TNF-α, IFN-y, interleukin (IL)-1β, IL-6 IL-17, IL-23, IL-10, and granulocyte macrophage colony stimulating factor (GM-CSF)) using high-sensitivity Luminex multiplexing technology (Bio-Rad Bio-Plex® 200 HTS) prepared by Millipore. Dietary intervention: Using methods established for an ongoing CRT with lentils, investigators will prepare 7 meals per participant per week to deliver a dose of 4.6 or 0 cups of lentils per week for the experimental and control groups. Meals are matched for macronutrient content (except for fiber), and ground turkey or chicken replaces lentils in the control meals. Dietary intervention will be 12 weeks in length with a possible extension to 13 weeks if participants either 1) miss 3 or more meals in a row at any point during the intervention or 2) miss any meals at all in the last week of the intervention prior to their final visit. To keep the meal intervention period between 12 and 13 weeks, participants will be dropped from the study if meal adherence failures result in more than a one week intervention extension. Participants will be instructed to consume food provided for their midday meal, and then to proactively reduce portion sizes and to not eat beyond fullness at the evening meal. This strategy exploits the satiety effect of pulses at the midday meal and the 'second meal effect' in which volitional consumption is reduced at the next meal, the evening meal. Each participant will be surveyed once weekly to determine whether they consumed the experimental meal that day, their perceptions of hunger, fullness, satiety, and satisfaction with that day's meal (at 4:00 pm), and their gastrointestinal comfort (level of bloating, flatulence, cramping, and comfort) throughout the day (at 8:00 pm). This methodology has been successfully implemented in our ongoing study to demonstrate that lentil meals are equally pleasing, produce greater satiety, and are well-tolerated. Gut microbiome analysis: Bulk DNA will be extracted from fecal samples using the Powersoil® DNA Isolation Kit (Mo Bio Laboratories Inc.). DNA will be shipped overnight to the University of Michigan, Center for Microbial Systems, for Illumina MiSeq amplicon sequencing of the 16S V4 variable region. Raw sequencing reads will be processed and curated using the mothur (v.1.39.5) software package, following the mothur MiSeq standard operating procedure, potentially chimeric sequences will be identified and removed using the Uchime (v4.2.40) algorithm, and taxonomic classifications will be assigned using the Bayesian classifier of the Ribosomal Database Project, and operational taxonomic units (OTUs) will be assigned in mothur using the VSEARCH distance-based clustering algorithm at the 97% sequence similarity threshold. Metabolomic analysis: Samples will be analyzed by high resolution liquid chromatography mass spectrometry (LCMS). Hydrophilic interaction chromatography (HILIC) and reverse-phase (RP) columns will be used for deep coverage. Metabolite identification will use fragmentation pattern matching, authentic standards and database matching with METLIN and the Human Metabome Database (HDB). Novel features of significant interest will be characterized with liquid chromatography mass spectrometry solid phase extraction nuclear magnetic resonance (LCMS-SPE-NMR). Pathway analysis will use XCMS and mummichog. Dietary analysis. Long-term dietary habits may create adaptations that influence the response to the short-term supplementation of Aronia and lentil. This study will use the most recent version (2018) of the web-based Diet History Questionnaire (DHQ III), a food frequency questionnaire designed for adults 19 and older, developed by staff at the Risk Factor Monitoring and Methods Branch (RFMMB) of the NIH National Cancer Institute. The outputs of the DHQ III include carbohydrate constituents, carotenoids and tocopherols, dietary constituents from supplements, fats, fatty acids and cholesterol, macronutrients and energy, minerals, protein constituents, and vitamins are dietary constituents and food groups available in the DHQ III output files.

Interventions

BEHAVIORALDietary Lentil

Participants in the Lentil arm of the study will consume midday meals containing 0.66 cups of lentils seven days per week for 12 weeks.

BEHAVIORALControl

Participants in the Control arm of the study will consume midday meals containing 0.00 cups of lentils seven days per week for 12 weeks.

Sponsors

Montana State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This study will utilize a parallel intervention of meals with 0.66 cups of lentils each day versus macronutrient-matched (not including fiber) meals with 0 cups of lentils each day for 12 weeks in OW/OB adults with demonstrated risk for T2D and CVD.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Waist circumference \> 35 inches for women and \> 40 inches for men * Non-fasting serum triglyceride concentration \> 175 mg/dl

Exclusion criteria

* Allergy to wheat * Taking medication that will influence cholesterol, lipids, or inflammation * Pregnant or use of hormonal contraceptive method * Have diabetes, a pacemaker, or other health conditions that may interfere with the study outcomes * Planning to undergo a weight loss intervention or change in exercise regimen

Design outcomes

Primary

MeasureTime frameDescription
Change in Fasting Serum Lipids and Glucose12 weeksConcentration of HDL, LDL, TG, and glucose in the serum after an overnight fast. Value reported as the change in value from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).
Change in Fasting Inflammatory Cytokines12 weeksConcentration of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-(IL)1beta, IL-6, IL-10, IL-17, IL-23, interferon-gamma, and granulocyte macrophage-colony stimulating factor) in the serum after an overnight fast. Value reported as the change from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)
Change in Postprandial Serum Triglyceride12 weeksArea under the curve for serum triglyceride concentration calculated from 0 - 5 hours post consumption of a meal containing 50 g of fat. Value reported as the change from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).
Change in Postprandial Serum Glucose12 weeksArea under the curve for serum glucose concentration calculated from 0 - 5 hours post consumption of a meal containing 50 g of fat. Value reported as the change from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)
Change in Postprandial Serum Inflammatory Cytokines12 weeksArea under the curve for inflammatory cytokine (tumor necrosis factor-alpha, interleukin-(IL)1beta, IL-6, IL-10, IL-17, IL-23, interferon-gamma, and granulocyte macrophage-colony stimulating factor) concentration calculated from 0 - 5 hours post consumption of a meal containing 50 g of fat. Value reported as the change in AUC for each cytokine from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).

Secondary

MeasureTime frameDescription
Gastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the Intervention12 weeksRatings of the gastrointestinal symptoms of bloating, cramping, discomfort, and flatulence over the 12-week intervention. All symptoms were qualitatively ranked as none, mild, moderate, or severe by participants. Numerical values were then assigned to all measures using a 4-point scale: (0 = none, 1 = mild, 2 = moderate, 3 = severe). Values reported represent the average from all surveys collected during the 12 week intervention.
Change in Body Fat Composition12 weeksChange in % Body Fat from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)
Change in Visceral Adipose Tissue12 weeksChange in the quantity of adipose tissue located within the abdominal compartment from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)
Change in Body Mass Index (BMI)12 weeksChange in BMI (kg/m\^2) from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).
Perceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the Intervention12 weeksRatings of hunger, fullness, satiety, satisfaction, desire to eat, and desire to consume additional food in response to mid-day meal consumption during the 12-week intervention. Ratings were scored on a scale of 0 to 10 with 0 representing no feelings of hunger, fullness, satiety, satisfaction, desire to eat, or consume additional food and 10 representing maximal feelings of hunger, fullness, satiety, satisfaction, desire to eat, or consume additional food. Reported values represent the average from all survey responses collected over the duration of the 12-week intervention period.

Other

MeasureTime frameDescription
Change in Habitual Diet12 monthsHealthy Eating Index (HEI) scores were obtained through DHQ III survey data output from before and after the 12 week intervention. Each category is scored on a scale of 0-5 or 0-10. For components of adequacy, high scores indicate higher intake of each component and are therefore desirable. For components of moderation, high scores indicate lower intake of each component and are therefore desirable. Total possible scores for components of adequacy are as follows: Total Fruits (5), Whole Fruits (5), Total Vegetables (5), Greens and Beans (5), Whole Grains (10), Dairy (10), Total Protein Foods (5), Seafood and Plant Proteins (5), Fatty acids (10). Total possible scores for components of moderation are as follows: Refined Grains (10), Sodium (10), Added sugar (10). Total HEI score is also reported as the sum of all components with a total possible score of 100 indicating healthiest possible diet. All values reported as the change in value from baseline to 12 weeks post intervention.

Countries

United States

Participant flow

Participants by arm

ArmCount
Lentil
0.66 cups lentils Dietary Lentil: Participants in the Lentil arm of the study will consume midday meals containing 0.66 cups of lentils seven days per week for 12 weeks.
20
Control
0.0 cups lentils Control: Participants in the Control arm of the study will consume midday meals containing 0.00 cups of lentils seven days per week for 12 weeks.
18
Total38

Baseline characteristics

CharacteristicLentilTotalControl
Age, Continuous50.65 years
STANDARD_DEVIATION 11.52
47.11 years
STANDARD_DEVIATION 13.14
43.20 years
STANDARD_DEVIATION 14.01
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants2 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants35 Participants17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
19 Participants36 Participants17 Participants
Region of Enrollment
United States
20 participants38 participants18 participants
Sex: Female, Male
Female
18 Participants35 Participants17 Participants
Sex: Female, Male
Male
2 Participants3 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 18
other
Total, other adverse events
0 / 200 / 18
serious
Total, serious adverse events
0 / 200 / 18

Outcome results

Primary

Change in Fasting Inflammatory Cytokines

Concentration of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-(IL)1beta, IL-6, IL-10, IL-17, IL-23, interferon-gamma, and granulocyte macrophage-colony stimulating factor) in the serum after an overnight fast. Value reported as the change from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)

Time frame: 12 weeks

ArmMeasureGroupValue (MEAN)Dispersion
LentilChange in Fasting Inflammatory Cytokinestumor necrosis factor-alpha1.47 pg/mlStandard Deviation 4.17
LentilChange in Fasting Inflammatory CytokinesIL-62.20 pg/mlStandard Deviation 5.52
LentilChange in Fasting Inflammatory CytokinesIL-23-28.54 pg/mlStandard Deviation 527.21
LentilChange in Fasting Inflammatory CytokinesIL-1beta0.65 pg/mlStandard Deviation 2.05
LentilChange in Fasting Inflammatory Cytokinesinterferon-gamma9.69 pg/mlStandard Deviation 143.72
LentilChange in Fasting Inflammatory CytokinesIL-103.46 pg/mlStandard Deviation 12.93
LentilChange in Fasting Inflammatory Cytokinesgranulocyte macrophage-colony stimulating factor3.00 pg/mlStandard Deviation 24.99
LentilChange in Fasting Inflammatory CytokinesIL-173.56 pg/mlStandard Deviation 12.62
ControlChange in Fasting Inflammatory Cytokinesgranulocyte macrophage-colony stimulating factor-4.53 pg/mlStandard Deviation 17.42
ControlChange in Fasting Inflammatory Cytokinestumor necrosis factor-alpha-0.76 pg/mlStandard Deviation 1.88
ControlChange in Fasting Inflammatory CytokinesIL-1beta0.04 pg/mlStandard Deviation 0.78
ControlChange in Fasting Inflammatory CytokinesIL-60.26 pg/mlStandard Deviation 1.79
ControlChange in Fasting Inflammatory CytokinesIL-100.62 pg/mlStandard Deviation 12.72
ControlChange in Fasting Inflammatory CytokinesIL-17-0.84 pg/mlStandard Deviation 4.93
ControlChange in Fasting Inflammatory CytokinesIL-23-12.27 pg/mlStandard Deviation 129.2
ControlChange in Fasting Inflammatory Cytokinesinterferon-gamma11.67 pg/mlStandard Deviation 85.84
Primary

Change in Fasting Serum Lipids and Glucose

Concentration of HDL, LDL, TG, and glucose in the serum after an overnight fast. Value reported as the change in value from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).

Time frame: 12 weeks

ArmMeasureGroupValue (MEAN)Dispersion
LentilChange in Fasting Serum Lipids and GlucoseCholesterol-0.11 mmol/LStandard Deviation 0.5
LentilChange in Fasting Serum Lipids and GlucoseTriglyceride-0.06 mmol/LStandard Deviation 0.73
LentilChange in Fasting Serum Lipids and GlucoseLDL-0.03 mmol/LStandard Deviation 0.43
LentilChange in Fasting Serum Lipids and GlucoseGlucose-0.06 mmol/LStandard Deviation 0.34
LentilChange in Fasting Serum Lipids and GlucoseHDL-0.07 mmol/LStandard Deviation 0.15
ControlChange in Fasting Serum Lipids and GlucoseGlucose-0.05 mmol/LStandard Deviation 0.44
ControlChange in Fasting Serum Lipids and GlucoseCholesterol0.36 mmol/LStandard Deviation 0.43
ControlChange in Fasting Serum Lipids and GlucoseHDL0.10 mmol/LStandard Deviation 0.14
ControlChange in Fasting Serum Lipids and GlucoseLDL0.30 mmol/LStandard Deviation 0.36
ControlChange in Fasting Serum Lipids and GlucoseTriglyceride-0.21 mmol/LStandard Deviation 0.54
Primary

Change in Postprandial Serum Glucose

Area under the curve for serum glucose concentration calculated from 0 - 5 hours post consumption of a meal containing 50 g of fat. Value reported as the change from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
LentilChange in Postprandial Serum Glucose-0.7 mmol*hr/LStandard Deviation 1.4
ControlChange in Postprandial Serum Glucose0.1 mmol*hr/LStandard Deviation 1.8
Primary

Change in Postprandial Serum Inflammatory Cytokines

Area under the curve for inflammatory cytokine (tumor necrosis factor-alpha, interleukin-(IL)1beta, IL-6, IL-10, IL-17, IL-23, interferon-gamma, and granulocyte macrophage-colony stimulating factor) concentration calculated from 0 - 5 hours post consumption of a meal containing 50 g of fat. Value reported as the change in AUC for each cytokine from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).

Time frame: 12 weeks

ArmMeasureGroupValue (MEAN)Dispersion
LentilChange in Postprandial Serum Inflammatory Cytokinestumor necrosis factor-alpha-7.59 pg*hr/mlStandard Deviation 21.85
LentilChange in Postprandial Serum Inflammatory CytokinesIL-1beta-4.06 pg*hr/mlStandard Deviation 9.94
LentilChange in Postprandial Serum Inflammatory CytokinesIL-6-12.42 pg*hr/mlStandard Deviation 31.92
LentilChange in Postprandial Serum Inflammatory CytokinesIL-10-43.64 pg*hr/mlStandard Deviation 133.11
LentilChange in Postprandial Serum Inflammatory CytokinesIL-17-27.07 pg*hr/mlStandard Deviation 83.07
LentilChange in Postprandial Serum Inflammatory CytokinesIL-23-234.36 pg*hr/mlStandard Deviation 941.87
LentilChange in Postprandial Serum Inflammatory Cytokinesinterferon-gamma-27.20 pg*hr/mlStandard Deviation 438.32
LentilChange in Postprandial Serum Inflammatory Cytokinesgranulocyte macrophage-colony stimulating factor-24.35 pg*hr/mlStandard Deviation 67.97
ControlChange in Postprandial Serum Inflammatory Cytokinesgranulocyte macrophage-colony stimulating factor-77.16 pg*hr/mlStandard Deviation 482.39
ControlChange in Postprandial Serum Inflammatory Cytokinestumor necrosis factor-alpha3.07 pg*hr/mlStandard Deviation 9.37
ControlChange in Postprandial Serum Inflammatory CytokinesIL-1713.82 pg*hr/mlStandard Deviation 31.64
ControlChange in Postprandial Serum Inflammatory CytokinesIL-1beta1.09 pg*hr/mlStandard Deviation 3.92
ControlChange in Postprandial Serum Inflammatory Cytokinesinterferon-gamma6.99 pg*hr/mlStandard Deviation 434.06
ControlChange in Postprandial Serum Inflammatory CytokinesIL-60.09 pg*hr/mlStandard Deviation 3.93
ControlChange in Postprandial Serum Inflammatory CytokinesIL-23122.67 pg*hr/mlStandard Deviation 731.23
ControlChange in Postprandial Serum Inflammatory CytokinesIL-108.69 pg*hr/mlStandard Deviation 38.5
Primary

Change in Postprandial Serum Triglyceride

Area under the curve for serum triglyceride concentration calculated from 0 - 5 hours post consumption of a meal containing 50 g of fat. Value reported as the change from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
LentilChange in Postprandial Serum Triglyceride-0.1 mmol*hr/LStandard Deviation 1.5
ControlChange in Postprandial Serum Triglyceride0.2 mmol*hr/LStandard Deviation 1.8
Secondary

Change in Body Fat Composition

Change in % Body Fat from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
LentilChange in Body Fat Composition-1.2 percentage of Body FatStandard Deviation 6.4
ControlChange in Body Fat Composition0.55 percentage of Body FatStandard Deviation 1.9
Secondary

Change in Body Mass Index (BMI)

Change in BMI (kg/m\^2) from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
LentilChange in Body Mass Index (BMI)-0.43 kg of mass per meter of height squaredStandard Deviation 1.21
ControlChange in Body Mass Index (BMI)-0.02 kg of mass per meter of height squaredStandard Deviation 0.96
Secondary

Change in Visceral Adipose Tissue

Change in the quantity of adipose tissue located within the abdominal compartment from baseline to 12 weeks post intervention (Value at 12 weeks minus value at baseline)

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
LentilChange in Visceral Adipose Tissue0.08 LitersStandard Deviation 0.92
ControlChange in Visceral Adipose Tissue0.17 LitersStandard Deviation 0.63
Secondary

Gastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the Intervention

Ratings of the gastrointestinal symptoms of bloating, cramping, discomfort, and flatulence over the 12-week intervention. All symptoms were qualitatively ranked as none, mild, moderate, or severe by participants. Numerical values were then assigned to all measures using a 4-point scale: (0 = none, 1 = mild, 2 = moderate, 3 = severe). Values reported represent the average from all surveys collected during the 12 week intervention.

Time frame: 12 weeks

ArmMeasureGroupValue (MEAN)Dispersion
LentilGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionFlatulence (lower scores indicate less flatulence)0.9 score on a scaleStandard Deviation 0.7
LentilGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionBloating (lower scores indicate less bloating)0.6 score on a scaleStandard Deviation 0.8
LentilGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionCramping (lower scores indicate less cramping)0.2 score on a scaleStandard Deviation 0.5
LentilGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionDiscomfort (lower scores indicate less abdominal discomfort)0.3 score on a scaleStandard Deviation 0.6
ControlGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionDiscomfort (lower scores indicate less abdominal discomfort)0.4 score on a scaleStandard Deviation 0.8
ControlGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionFlatulence (lower scores indicate less flatulence)0.8 score on a scaleStandard Deviation 0.9
ControlGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionCramping (lower scores indicate less cramping)0.3 score on a scaleStandard Deviation 0.7
ControlGastrointestinal Symptoms of Bloating, Cramping, Discomfort, and Flatulence During the InterventionBloating (lower scores indicate less bloating)0.7 score on a scaleStandard Deviation 0.9
Secondary

Perceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the Intervention

Ratings of hunger, fullness, satiety, satisfaction, desire to eat, and desire to consume additional food in response to mid-day meal consumption during the 12-week intervention. Ratings were scored on a scale of 0 to 10 with 0 representing no feelings of hunger, fullness, satiety, satisfaction, desire to eat, or consume additional food and 10 representing maximal feelings of hunger, fullness, satiety, satisfaction, desire to eat, or consume additional food. Reported values represent the average from all survey responses collected over the duration of the 12-week intervention period.

Time frame: 12 weeks

ArmMeasureGroupValue (MEAN)Dispersion
LentilPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionFullness (lower scores indicate low fullness after consuming meal)6.3 units on a scale (0=lowest, 10=highest)Standard Deviation 2.3
LentilPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionDesire to eat (lower scores indicate little desire to eat more food after consuming the meal)4.0 units on a scale (0=lowest, 10=highest)Standard Deviation 2.2
LentilPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionSatisfaction (lower scores indicate low satiety after consuming the meal)6.2 units on a scale (0=lowest, 10=highest)Standard Deviation 2.1
LentilPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionAmount of food that could be eaten (lower scores indicate that little food is desired)3.6 units on a scale (0=lowest, 10=highest)Standard Deviation 1.9
LentilPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionHunger (lower scores indicate low hunger after consuming meal)3.6 units on a scale (0=lowest, 10=highest)Standard Deviation 2
ControlPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionAmount of food that could be eaten (lower scores indicate that little food is desired)4.0 units on a scale (0=lowest, 10=highest)Standard Deviation 2
ControlPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionHunger (lower scores indicate low hunger after consuming meal)3.9 units on a scale (0=lowest, 10=highest)Standard Deviation 2.1
ControlPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionFullness (lower scores indicate low fullness after consuming meal)6.2 units on a scale (0=lowest, 10=highest)Standard Deviation 2
ControlPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionSatisfaction (lower scores indicate low satiety after consuming the meal)6.1 units on a scale (0=lowest, 10=highest)Standard Deviation 1.9
ControlPerceptions of Hunger, Fullness, Satiety, and Satisfaction After Mid-day Meal During the InterventionDesire to eat (lower scores indicate little desire to eat more food after consuming the meal)4.2 units on a scale (0=lowest, 10=highest)Standard Deviation 2.2
Other Pre-specified

Change in Habitual Diet

Healthy Eating Index (HEI) scores were obtained through DHQ III survey data output from before and after the 12 week intervention. Each category is scored on a scale of 0-5 or 0-10. For components of adequacy, high scores indicate higher intake of each component and are therefore desirable. For components of moderation, high scores indicate lower intake of each component and are therefore desirable. Total possible scores for components of adequacy are as follows: Total Fruits (5), Whole Fruits (5), Total Vegetables (5), Greens and Beans (5), Whole Grains (10), Dairy (10), Total Protein Foods (5), Seafood and Plant Proteins (5), Fatty acids (10). Total possible scores for components of moderation are as follows: Refined Grains (10), Sodium (10), Added sugar (10). Total HEI score is also reported as the sum of all components with a total possible score of 100 indicating healthiest possible diet. All values reported as the change in value from baseline to 12 weeks post intervention.

Time frame: 12 months

ArmMeasureGroupValue (MEAN)Dispersion
LentilChange in Habitual DietTotal Vegetables (0-5 score possible, higher indicating healthier score)0.6 HEI Scores from DHQIIIStandard Deviation 1.1
LentilChange in Habitual DietGreen and Beans (0-5 score possible, higher indicating healthier score)0.8 HEI Scores from DHQIIIStandard Deviation 1.1
LentilChange in Habitual DietWhole Grains (0-10 score possible, higher indicating healthier score)0.4 HEI Scores from DHQIIIStandard Deviation 1.8
LentilChange in Habitual DietDairy (0-10 score possible, higher indicating healthier score)-0.9 HEI Scores from DHQIIIStandard Deviation 2.3
LentilChange in Habitual DietTotal Protein Foods (0-5 score possible, higher indicating healthier score)0.3 HEI Scores from DHQIIIStandard Deviation 0.5
LentilChange in Habitual DietSeafood and Plant Proteins (0-5 score possible, higher indicating healthier score)0.6 HEI Scores from DHQIIIStandard Deviation 0.9
LentilChange in Habitual DietFatty Acids (0-10 score possible, higher indicating healthier score)0.1 HEI Scores from DHQIIIStandard Deviation 2.5
LentilChange in Habitual DietRefined Grains (0-10 score possible, higher indicating healthier score)-0.3 HEI Scores from DHQIIIStandard Deviation 2.4
LentilChange in Habitual DietSodium (0-10 score possible, higher indicating healthier score)-1.9 HEI Scores from DHQIIIStandard Deviation 2.5
LentilChange in Habitual DietAdded Sugars (0-10 score possible, higher indicating healthier score)0.8 HEI Scores from DHQIIIStandard Deviation 2
LentilChange in Habitual DietSaturated Fats (0-10 score possible, higher indicating healthier score)0.8 HEI Scores from DHQIIIStandard Deviation 2.8
LentilChange in Habitual DietTotal HEI (0-100 score possible, higher indicating healthier)0.3 HEI Scores from DHQIIIStandard Deviation 9.2
LentilChange in Habitual DietTotal Fruits (0-5 score possible, higher indicating healthier score)-0.1 HEI Scores from DHQIIIStandard Deviation 1.6
LentilChange in Habitual DietWhole Fruits (0-5 score possible, higher indicating healthier score)-0.1 HEI Scores from DHQIIIStandard Deviation 1.6
ControlChange in Habitual DietSaturated Fats (0-10 score possible, higher indicating healthier score)0.7 HEI Scores from DHQIIIStandard Deviation 2.4
ControlChange in Habitual DietTotal Vegetables (0-5 score possible, higher indicating healthier score)0.1 HEI Scores from DHQIIIStandard Deviation 1.1
ControlChange in Habitual DietRefined Grains (0-10 score possible, higher indicating healthier score)-2.0 HEI Scores from DHQIIIStandard Deviation 2
ControlChange in Habitual DietGreen and Beans (0-5 score possible, higher indicating healthier score)-0.1 HEI Scores from DHQIIIStandard Deviation 1.3
ControlChange in Habitual DietTotal Fruits (0-5 score possible, higher indicating healthier score)-0.8 HEI Scores from DHQIIIStandard Deviation 1.5
ControlChange in Habitual DietWhole Grains (0-10 score possible, higher indicating healthier score)0.6 HEI Scores from DHQIIIStandard Deviation 1.3
ControlChange in Habitual DietSodium (0-10 score possible, higher indicating healthier score)-1.5 HEI Scores from DHQIIIStandard Deviation 2.5
ControlChange in Habitual DietDairy (0-10 score possible, higher indicating healthier score)-1.1 HEI Scores from DHQIIIStandard Deviation 2
ControlChange in Habitual DietTotal HEI (0-100 score possible, higher indicating healthier)-3.5 HEI Scores from DHQIIIStandard Deviation 7.9
ControlChange in Habitual DietTotal Protein Foods (0-5 score possible, higher indicating healthier score)0.0 HEI Scores from DHQIIIStandard Deviation 0.3
ControlChange in Habitual DietAdded Sugars (0-10 score possible, higher indicating healthier score)0.5 HEI Scores from DHQIIIStandard Deviation 1.9
ControlChange in Habitual DietSeafood and Plant Proteins (0-5 score possible, higher indicating healthier score)0.3 HEI Scores from DHQIIIStandard Deviation 0.9
ControlChange in Habitual DietWhole Fruits (0-5 score possible, higher indicating healthier score)-0.5 HEI Scores from DHQIIIStandard Deviation 1.3
ControlChange in Habitual DietFatty Acids (0-10 score possible, higher indicating healthier score)0.4 HEI Scores from DHQIIIStandard Deviation 2.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026